Pluri (PLUR) EBITDA Margin Growth (1y) (2012 - 2025)
Pluri (PLUR) EBITDA Margin Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
-60,640.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-60,640.00 |
| Sep 30, 2025 |
-41,502.00 |
| Jun 30, 2025 |
462,185.00 |
| Mar 31, 2025 |
652,973.00 |
| Dec 31, 2024 |
228,530.00 |
| Sep 30, 2024 |
836,293.00 |
| Jun 30, 2024 |
-38,992.00 |
| Mar 31, 2024 |
36,655.00 |
| Dec 31, 2023 |
32.90 Mn |
| Sep 30, 2023 |
-199,994.00 |
| Mar 31, 2023 |
-368,442.00 |
| Dec 31, 2019 |
-1.10 Mn |
| Dec 31, 2018 |
27,200.00 |
| Dec 31, 2015 |
647,900.00 |
| Sep 30, 2015 |
10,526.00 |
| Dec 31, 2014 |
72,526.00 |
| Sep 30, 2014 |
-80,316.00 |
| Jun 30, 2014 |
-344,098.00 |
| Mar 31, 2014 |
-671,754.00 |
| Dec 31, 2013 |
-485,328.00 |
